First Trust NYSE Arca Biotechnology Index Fund (FBT)
$259.65-1.61%Close
SELLBEAR · day 1
Key stats
ETF · income quality metrics
- AUM
- $2.9B
- Expense
- 0.55%
- Quality
- 42
- Beta
- 0.89
- Max DD
- -32.36%
- 1Y
- +41.22%
- 3Y
- +79.13%
- 5Y
- +63.59%
- 1W
- -2.01%
- 1M
- -1.74%
- vs SPY 1W
- -1.87%
- vs SPY 1M
- -4.25%
Industry peers
FMP comparable companies · ranked by market cap
- CGIECapital Group International Equity ETF$2.3B$36.45
- HFXINYLI FTSE International Equity Currency Neutral ETF$1.9B$36.76
- OIHVanEck Oil Services ETF$1.4B$390.48
- FNXFirst Trust Mid Cap Core AlphaDEX Fund$1.4B$137.12
- FTAFirst Trust Large Cap Value AlphaDEX Fund$1.3B$98.58
- ILCViShares Morningstar Value ETF$1.3B$108.47
- FVALFidelity Value Factor ETF$1.3B$82.57
- GPIXGoldman Sachs S&P 500 Premium Income ETF$1.2B$56.42
- LGLVState Street SPDR US Large Cap Low Volatility Index ETF$1.1B$179.45
- QQXTFirst Trust NASDAQ-100 Ex-Technology Sector Index Fund$1.1B$97.78
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on FBT?
- LOPJLB’s latest quantitative signal on First Trust NYSE Arca Biotechnology Index Fund (FBT) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is FBT in?
- First Trust NYSE Arca Biotechnology Index Fund (FBT) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does First Trust NYSE Arca Biotechnology Index Fund (FBT) do?
- The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.